Redefining
Breast Cancer Treatment

The only image-guided prone LINAC
designed exclusively for breast cancer radiotherapy

The logo reads 'MAMMOKNIFE' in black outlined text on a transparent background.

Rethinking
how and where
breast radiotherapy
can be delivered

MammoKnife Supports:

    • Supports improved patient outcomes and tissue preservation

    • Radiobiological & Clinical Benefits

    • Distributed entrance and exit dose avoid hot spots to non-target breast tissue

    • Reduced acute radiation dermatitis

    • Reduced long-term fibrosis and improved cosmetic outcomes

    • Allows for installation in standard clinical environments or any health center setting.

    • No vault required, increasing access and reducing facility cost and complexity for costly bunkers

  • Engineered to deliver unparalleled precision and dose conformity across whole-breast radiotherapy, with or without boost, accelerated partial breast radiotherapy, and stereotactic ablative radiotherapy.

No vault, bunker, or major construction required

The MAMMOKNIFE is a dedicated breast radiotherapy platform designed to improve clinical precision, patient comfort, and treatment workflow. Its self-shielded, compact design allows installation in standard clinical environments.  

By treating patients in the prone position, MAMMOKNIFE isolates the breast from surrounding organs and reduces radiation exposure to the heart and lungs supporting improved outcomes and patient safety while enabling a more comfortable treatment experience.

Stereotactic surgery intended to support whole-breast radiotherapy, with or without boost, as well as accelerated partial breast radiotherapy or stereotactic ablative radiotherapy.

Download Brochure

How MAMMOKNIFE works

Rotational LINAC

The system combines high-quality image guidance within a shielded environment to ensure precise radiotherapy delivery.

Reduced Skin Toxicity

The patient is positioned prone with the breast falling through the table, allowing the treatment beam to travel parallel to the chest wall.

Self-Shielded

Only the breast is exposed within the radiation field, avoiding dose to the heart, lungs, and surrounding structures.

Developed in partnership with

Logo for gKteso Technologies & Solutions with stylized text in blue and green colors

MAMMOKNIFE is currently in development.
The device has not been reviewed or cleared by the FDA and is not available for commercial use.